|
Volume 270,
Number 22,
Issue of June 2, pp. 13246-13253, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Vav Is Necessary
for Prolactin-stimulated Proliferation and Is Translocated into the
Nucleus of a T-cell Line
Charles V.
Clevenger
,
Winnie
Ngo
,
Deborah
L.
Sokol
,
Selina M.
Luger
,
, Alan M.
Gewirtz
Stimulation of the prolactin receptor (PRLr) with ligand
activates multiple kinase cascades. The proximal mediators involved in
the activation of the PRL-activated Raf-1 cascade in T-cells, however,
remain poorly characterized. The role of one proximal signaling
protein, namely p95 , during PRLr signal
transduction was examined in the Nb2 T-cell line. The novel results
obtained here indicate that Vav is transiently associated with the PRLr
and is necessary for PRL-stimulated proliferation. During PRL
stimulation, a rapid and dramatic increase in guanine nucleotide
exchange factor (GEF) activity was found to be associated with Vav
immunoprecipitates. Concomitantly, an increase in Vav phosphorylation
on serine-threonine residues was observed. The Vav-associated GEF
activation could be inhibited by staurosporine and calphostin, but not
herbimycin, suggesting a modulatory role for phosphorylation at
serine-threonine residues. Treatment of Nb2 cells with antisense Vav
oligonucleotide ablated Vav expression and blocked PRL-driven
proliferation, but failed to inhibit PRL-induced GEF activation within
Nb2 lysates. These data indicate that GEF activity may not be intrinsic
to Vav as has been previously suggested, but either resides in or is
complemented by an associated GEF. Subsequent to the transient
activation of associated GEF activity, Vav was found to translocate
into the Nb2 cell nucleus. Thus, Vav may utilize two independent
mechanisms in T-cells, namely the activation of an associated GEF and
direct nuclear internalization, to mediate PRLr signaling.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Bachelot and N. Binart
Reproductive role of prolactin
Reproduction,
February 1, 2007;
133(2):
361 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Stephenson, A. V. Miletic, T. Kloeppel, S. Kusin, and W. Swat
Vav Proteins Regulate the Plasma Cell Program and Secretory Ig Production
J. Immunol.,
December 15, 2006;
177(12):
8620 - 8625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Gadd and C. V. Clevenger
Ligand-Independent Dimerization of the Human Prolactin Receptor Isoforms: Functional Implications
Mol. Endocrinol.,
November 1, 2006;
20(11):
2734 - 2746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Opalinska, B. Machalinski, J. Ratajczak, M. Z. Ratajczak, and A. M. Gewirtz
Multigene Targeting with Antisense Oligodeoxynucleotides: An Exploratory Study Using Primary Human Leukemia Cells
Clin. Cancer Res.,
July 1, 2005;
11(13):
4948 - 4954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Miller, J. E. DeMaria, D. O. Freier, A. M. Riegel, and C. V. Clevenger
Novel Association of Vav2 and Nek3 Modulates Signaling through the Human Prolactin Receptor
Mol. Endocrinol.,
April 1, 2005;
19(4):
939 - 949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Katzav
Vav1: an oncogene that regulates specific transcriptional activation of T cells
Blood,
April 1, 2004;
103(7):
2443 - 2451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Acosta, R. M. Munoz, L. Gonzalez, A. Subtil-Rodriguez, M. A. Dominguez-Caceres, J. M. Garcia-Martinez, A. Calcabrini, I. Lazaro-Trueba, and J. Martin-Perez
Src Mediates Prolactin-Dependent Proliferation of T47D and MCF7 Cells via the Activation of Focal Adhesion Kinase/Erk1/2 and Phosphatidylinositol 3-Kinase Pathways
Mol. Endocrinol.,
November 1, 2003;
17(11):
2268 - 2282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Qi, A. Fournier, J. Grenier, C. Fillion, Y. Labrie, and C. Labrie
Isolation of the Novel Human Guanine Nucleotide Exchange Factor Src Homology 3 Domain-Containing Guanine Nucleotide Exchange Factor (SGEF) and of C-Terminal SGEF, an N-Terminally Truncated Form of SGEF, the Expression of Which Is Regulated by Androgen in Prostate Cancer Cells
Endocrinology,
May 1, 2003;
144(5):
1742 - 1752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Lanning, R. Ruiz-Velasco, and C. L. Williams
Novel Mechanism of the Co-regulation of Nuclear Transport of SmgGDS and Rac1
J. Biol. Chem.,
March 28, 2003;
278(14):
12495 - 12506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler
The Role of Prolactin in Mammary Carcinoma
Endocr. Rev.,
February 1, 2003;
24(1):
1 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Rycyzyn and C. V. Clevenger
The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer
PNAS,
May 14, 2002;
99(10):
6790 - 6795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Luger, S. G. O'Brien, J. Ratajczak, M. Z. Ratajczak, R. Mick, E. A. Stadtmauer, P. C. Nowell, J. M. Goldman, and A. M. Gewirtz
Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study
Blood,
February 15, 2002;
99(4):
1150 - 1158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C V Clevenger and J B Kline
Prolactin receptor signal transduction
Lupus,
October 1, 2001;
10(10):
706 - 718.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Fleenor and M. Freemark
Prolactin Induction of Insulin Gene Transcription: Roles of Glucose and Signal Transducer and Activator of Transcription 5
Endocrinology,
July 1, 2001;
142(7):
2805 - 2810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Kline, D. J. Moore, and C. V. Clevenger
Activation and Association of the Tec Tyrosine Kinase with the Human Prolactin Receptor: Mapping of a Tec/Vav1-Receptor Binding Site
Mol. Endocrinol.,
May 1, 2001;
15(5):
832 - 841.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. Bertagnolo, M. Marchisio, F. Brugnoli, A. Bavelloni, L. Boccafogli, M. L. Colamussi, and S. Capitani
Requirement of Tyrosine-phosphorylated Vav for Morphological Differentiation of All-trans-Retinoic Acid-treated HL-60 Cells
Cell Growth Differ.,
April 1, 2001;
12(4):
193 - 200.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M.-P. Gulli and M. Peter
Temporal and spatial regulation of Rho-type guanine-nucleotide exchange factors: the yeast perspective
Genes & Dev.,
February 15, 2001;
15(4):
365 - 379.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. A. Rycyzyn, S. C. Reilly, K. OMalley, and C. V. Clevenger
Role of Cyclophilin B in Prolactin Signal Transduction and Nuclear Retrotranslocation
Mol. Endocrinol.,
August 1, 2000;
14(8):
1175 - 1186.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Olazabal, J. Muñoz, S. Ogueta, E. Obregón, and J. P. García-Ruiz
Prolactin (PRL)-PRL Receptor System Increases Cell Proliferation Involving JNK (c-Jun Amino Terminal Kinase) and AP-1 Activation: Inhibition by Glucocorticoids
Mol. Endocrinol.,
April 1, 2000;
14(4):
564 - 575.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X. R. Bustelo
Regulatory and Signaling Properties of the Vav Family
Mol. Cell. Biol.,
March 1, 2000;
20(5):
1461 - 1477.
[Full Text]
|
 |
|

|
 |

|
 |
 
K. M. McAveney, M. L. Book, P. Ling, J. Chebath, and L.-y. Yu-Lee
Association of 2',5'-Oligoadenylate Synthetase with the Prolactin (PRL) Receptor: Alteration in PRL-Inducible Stat1 (Signal Transducer and Activator of Transcription 1) Signaling to the IRF-1 (Interferon-Regulatory Factor 1) Promoter
Mol. Endocrinol.,
February 1, 2000;
14(2):
295 - 306.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. E. Borg, M. Zhang, D. Hegge, R. L. Stephen, D. J. Buckley, N. S. Magnuson, and A. R. Buckley
Prolactin Regulation of pim-1 Expression: Positive and Negative Promoter Elements
Endocrinology,
December 1, 1999;
140(12):
5659 - 5668.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Morales, M. V. Carretero, H. Geronimo, S. G. Copín, M. L. Gaspar, M. A. R. Marcos, and J. Martín-Pérez
Influence of Prolactin on the Differentiation of Mouse B-Lymphoid Precursors
Cell Growth Differ.,
August 1, 1999;
10(8):
583 - 590.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. V. Salojin, J. Zhang, and T. L. Delovitch
TCR and CD28 Are Coupled Via ZAP-70 to the Activation of the Vav/Rac-1-/PAK-1/p38 MAPK Signaling Pathway
J. Immunol.,
July 15, 1999;
163(2):
844 - 853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Germani, F. Romero, M. Houlard, J. Camonis, S. Gisselbrecht, S. Fischer, and N. Varin-Blank
hSiah2 Is a New Vav Binding Protein Which Inhibits Vav-Mediated Signaling Pathways
Mol. Cell. Biol.,
May 1, 1999;
19(5):
3798 - 3807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Sokol, X. Zhang, P. Lu, and A. M. Gewirtz
Real time detection of DNA·RNA hybridization in living cells
PNAS,
September 29, 1998;
95(20):
11538 - 11543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
Endocr. Rev.,
June 1, 1998;
19(3):
225 - 268.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Romero, A. Germani, E. Puvion, J. Camonis, N. Varin-Blank, S. Gisselbrecht, and S. Fischer
Vav Binding to Heterogeneous Nuclear Ribonucleoprotein (hnRNP) C. EVIDENCE FOR Vav-hnRNP INTERACTIONS IN AN RNA-DEPENDENT MANNER
J. Biol. Chem.,
March 6, 1998;
273(10):
5923 - 5931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-P. Chang, Y. Ye, and C. V. Clevenger
Stoichiometric Structure-Function Analysis of the Prolactin Receptor Signaling Domain by Receptor Chimeras
Mol. Cell. Biol.,
February 1, 1998;
18(2):
896 - 905.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Shigematsu, H. Iwasaki, T. Otsuka, Y. Ohno, F. Arima, and Y. Niho
Role of the vav Proto-oncogene Product (Vav) in Erythropoietin-mediated Cell Proliferation and Phosphatidylinositol 3-Kinase Activity
J. Biol. Chem.,
May 30, 1997;
272(22):
14334 - 14340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Clevenger, K. Thickman, W. Ngo, W.-P. Chang, S. Takayama, and J. C. Reed
Role of Bag-1 in the Survival and Proliferation of the Cytokine-Dependent Lymphocyte Lines, Ba/F3 and Nb2
Mol. Endocrinol.,
May 1, 1997;
11(5):
608 - 618.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Miyakawa, A. Oda, B. J. Druker, K. Ozaki, M. Handa, H. Ohashi, and Y. Ikeda
Thrombopoietin and Thrombin Induce Tyrosine Phosphorylation of Vav in Human Blood Platelets
Blood,
April 15, 1997;
89(8):
2789 - 2798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Song, J. Gomez, L. F. Stancato, and J. Rivera
Association of a p95 Vav-containing Signaling Complex with the Fcepsilon RI gamma Chain in the RBL-2H3 Mast Cell Line. EVIDENCE FOR A CONSTITUTIVE IN VIVO ASSOCIATION OF Vav WITH Grb2, Raf-1, AND ERK2 IN AN ACTIVE COMPLEX
J. Biol. Chem.,
October 25, 1996;
271(43):
26962 - 26970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Duan, D. I.H. Linzer, and G. Gibori
Cloning and Characterization of an Ovarian-specific Protein That Associates with the Short Form of the Prolactin Receptor
J. Biol. Chem.,
June 28, 1996;
271(26):
15602 - 15607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Bonnefoy-Berard, A Munshi, I Yron, S Wu, T. Collins, M Deckert, T Shalom- Barak, L Giampa, E Herbert, J Hernandez, et al.
Vav: function and regulation in hematopoietic cell signaling
Stem Cells,
May 1, 1996;
14(3):
250 - 268.
[Abstract]
|
 |
|

|
 |

|
 |
 
M. Houlard, R. Arudchandran, F. Regnier-Ricard, A. Germani, S. Gisselbrecht, U. Blank, J. Rivera, and N. Varin-Blank
Vav1 Is a Component of Transcriptionally Active Complexes
J. Exp. Med.,
May 6, 2002;
195(9):
1115 - 1127.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|